118 related articles for article (PubMed ID: 38235873)
21. Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase.
Fan G; Aleem S; Yang M; Miller WT; Tonks NK
J Biol Chem; 2015 Jun; 290(26):15934-47. PubMed ID: 25897081
[TBL] [Abstract][Full Text] [Related]
22. Regulation of Src and Csk nonreceptor tyrosine kinases in the filasterean Ministeria vibrans.
Schultheiss KP; Craddock BP; Suga H; Miller WT
Biochemistry; 2014 Mar; 53(8):1320-9. PubMed ID: 24520931
[TBL] [Abstract][Full Text] [Related]
23. Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes.
González-Sánchez A; Jaraíz-Rodríguez M; Domínguez-Prieto M; Herrero-González S; Medina JM; Tabernero A
Oncotarget; 2016 Aug; 7(31):49819-49833. PubMed ID: 27391443
[TBL] [Abstract][Full Text] [Related]
24. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation.
Ayrapetov MK; Nam NH; Ye G; Kumar A; Parang K; Sun G
J Biol Chem; 2005 Jul; 280(27):25780-7. PubMed ID: 15890649
[TBL] [Abstract][Full Text] [Related]
25. Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk.
Van Slyke P; Coll ML; Master Z; Kim H; Filmus J; Dumont DJ
Mol Cell Biol; 2005 May; 25(9):3831-41. PubMed ID: 15831486
[TBL] [Abstract][Full Text] [Related]
26. Cooperative role of caveolin-1 and C-terminal Src kinase binding protein in C-terminal Src kinase-mediated negative regulation of c-Src.
Place AT; Chen Z; Bakhshi FR; Liu G; O'Bryan JP; Minshall RD
Mol Pharmacol; 2011 Oct; 80(4):665-72. PubMed ID: 21778303
[TBL] [Abstract][Full Text] [Related]
27. Positive and Negative Regulatory Roles of C-Terminal Src Kinase (CSK) in FcεRI-Mediated Mast Cell Activation, Independent of the Transmembrane Adaptor PAG/CSK-Binding Protein.
Potuckova L; Draberova L; Halova I; Paulenda T; Draber P
Front Immunol; 2018; 9():1771. PubMed ID: 30116247
[TBL] [Abstract][Full Text] [Related]
28. Sequence specificity of C-terminal Src kinase (CSK)--a comparison with Src-related kinases c-Fgr and Lyn.
Ruzzene M; Songyang Z; Marin O; Donella-Deana A; Brunati AM; Guerra B; Agostinis P; Cantley LC; Pinna LA
Eur J Biochem; 1997 Jun; 246(2):433-9. PubMed ID: 9208935
[TBL] [Abstract][Full Text] [Related]
29. Junctional adhesion molecule-A suppresses platelet integrin αIIbβ3 signaling by recruiting Csk to the integrin-c-Src complex.
Naik MU; Caplan JL; Naik UP
Blood; 2014 Feb; 123(9):1393-402. PubMed ID: 24300854
[TBL] [Abstract][Full Text] [Related]
30. Functional analysis of Csk in signal transduction through the B-cell antigen receptor.
Hata A; Sabe H; Kurosaki T; Takata M; Hanafusa H
Mol Cell Biol; 1994 Nov; 14(11):7306-13. PubMed ID: 7935444
[TBL] [Abstract][Full Text] [Related]
31. Fulvestrant-induced cell death and proteasomal degradation of estrogen receptor α protein in MCF-7 cells require the CSK c-Src tyrosine kinase.
Yeh WL; Shioda K; Coser KR; Rivizzigno D; McSweeney KR; Shioda T
PLoS One; 2013; 8(4):e60889. PubMed ID: 23593342
[TBL] [Abstract][Full Text] [Related]
32. Cuproptosis-related gene SERPINE1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
Feng L; Li G; Li D; Duan G; Liu J
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10851-10865. PubMed ID: 37318594
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of the role of c-terminal Src kinase in dengue virus replication.
Kumar R; Agrawal T; Khan NA; Nakayama Y; Medigeshi GR
Sci Rep; 2016 Jul; 6():30490. PubMed ID: 27457684
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of the csk gene suppresses tumor metastasis in vivo.
Nakagawa T; Tanaka S; Suzuki H; Takayanagi H; Miyazaki T; Nakamura K; Tsuruo T
Int J Cancer; 2000 Nov; 88(3):384-91. PubMed ID: 11054667
[TBL] [Abstract][Full Text] [Related]
35. Csk homologous kinase (CHK), unlike Csk, enhances MAPK activation via Ras-mediated signaling in a Src-independent manner.
Zagozdzon R; Kaminski R; Fu Y; Fu W; Bougeret C; Avraham HK
Cell Signal; 2006 Jun; 18(6):871-81. PubMed ID: 16168623
[TBL] [Abstract][Full Text] [Related]
36. SH3-domain mutations selectively disrupt Csk homodimerization or PTPN22 binding.
Brian BF; Sjaastad FV; Freedman TS
Sci Rep; 2022 Apr; 12(1):5875. PubMed ID: 35393453
[TBL] [Abstract][Full Text] [Related]
37. STAP-2 negatively regulates BCR-mediated B cell activation by recruiting tyrosine-protein kinase CSK to LYN.
Kashiwakura JI; Kawahara S; Inagaki I; Inui K; Saitoh K; Kagohashi K; Sasaki Y; Kobayashi F; Kitai Y; Muromoto R; Oritani K; Matsuda T
FEBS Lett; 2023 Oct; 597(19):2433-2445. PubMed ID: 37669828
[TBL] [Abstract][Full Text] [Related]
38. The tyrosine kinase Csk dimerizes through Its SH3 domain.
Levinson NM; Visperas PR; Kuriyan J
PLoS One; 2009 Nov; 4(11):e7683. PubMed ID: 19888460
[TBL] [Abstract][Full Text] [Related]
39. Antiproliferative effect of sulindac in colonic neoplasia prevention: role of COOH-terminal Src kinase.
Kunte DP; Wali RK; Koetsier JL; Roy HK
Mol Cancer Ther; 2008 Jul; 7(7):1797-806. PubMed ID: 18644992
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo suppression of osteoclast function by adenovirus vector-induced csk gene.
Miyazaki T; Takayanagi H; Isshiki M; Takahashi T; Okada M; Fukui Y; Oda H; Nakamura K; Hirai H; Kurokawa T; Tanaka S
J Bone Miner Res; 2000 Jan; 15(1):41-51. PubMed ID: 10646113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
